Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Inner Ear Disease

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Inner Ear Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brea, B; García-Berrocal, JR; Lobo, D; Tuñón, M; Villarreal, I1

Other Studies

1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Inner Ear Disease

ArticleYear
Intratympanic gadolinium magnetic resonance imaging supports the role of endolymphatic hydrops in the pathogenesis of immune-mediated inner-ear disease.
    The Journal of laryngology and otology, 2018, Volume: 132, Issue:6

    Topics: Adolescent; Adult; Aged; Audiometry, Pure-Tone; Autoimmune Diseases; Contrast Media; Endolymphatic Hydrops; Female; Heterocyclic Compounds; Humans; Imaging, Three-Dimensional; Injection, Intratympanic; Labyrinth Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Prospective Studies; Young Adult

2018